S100A4 silencing inhibited mitochondrial complex I activity, reduced cellular ATP levels, and decreased invasive and metastasic properties as well as tumor growth in vivo, suggesting a link between mitochondrial function and S100A4. The gene discussed is S100A4; the disease is neoplasm.